Oncodesign Precision Medicine SA News - ALOPM

Oncodesign Precision Medicine Obtains Deep Tech Development Funding for Its ANIMUS Program

ANIMUS program: development of proprietary methods using AI to optimize molecules derived from our Nanocyclix® technology, for faster selection...

Oncodesign Precision Medicine annonce le résultat de son augmentation de capital d’un montant d’environ 2 M€

Regulatory News: Ce communiqué et les informations qu’il contient ne doivent pas être distribués, directement ou indirectement, aux Etats-Unis...

Oncodesign Precision Medicine obtient des subventions FEDER d’un montant total de 2,1 M€ pour son programme COMETE

Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN : FR001400CM63 ; Mnémonique : ALOPM) (ALOPM), entreprise biopharmaceutique spécialisée...

Oncodesign Precision Medicine : Bilan semestriel du contrat de liquidité confié à la société TP ICAP (Europe)

Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN : FR001400CM63 ; Mnémonique : ALOPM) (Paris:ALOPM), entreprise biopharmaceutique...

TP ICAP Midcap Initiates Coverage of Oncodesign Precision Medicine With a “Buy” Recommendation

Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN : FR001400CM63 ; Mnemonic : ALOPM) (Paris:ALOPM), a biopharmaceutical company...

Oncodesign Precision Medicine Announces a 6 Million Euros Bank Financing from Caisse d’Épargne Bourgogne Franche Comté, Crédit Agricole de Champagne Bourgogne and Société Générale

This non-dilutive financing enables OPM to continue the clinical development of OPM-101 and to support the development of its products portfolio...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Oncodesign Precision Medicine SA (ALOPM)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

ALOPM News

Oncodesign Precision Medicine Obtains Deep Tech Development Funding for Its ANIMUS Program

Oncodesign Precision Medicine annonce le résultat de son augmentation de capital d’un montant d’environ 2 M€

Oncodesign Precision Medicine obtient des subventions FEDER d’un montant total de 2,1 M€ pour son programme COMETE

Oncodesign Precision Medicine : Bilan semestriel du contrat de liquidité confié à la société TP ICAP (Europe)

TP ICAP Midcap Initiates Coverage of Oncodesign Precision Medicine With a “Buy” Recommendation

Oncodesign Precision Medicine Announces a 6 Million Euros Bank Financing from Caisse d’Épargne Bourgogne Franche Comté, Crédit Agricole de Champagne Bourgogne and Société Générale

OPM Announces Positive Interim Results of Its Phase 1 Study Evaluating OPM-101 in Healthy Volunteers

OPM met à disposition son rapport financier du 1er semestre 2023

OPM annonce ses résultats du 1er semestre 2023

ALOPM Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Oncodesign Precision Medicine SA (ALOPM) News

Oncodesign Precision Medicine SA (ALOPM)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

ALOPM News

Oncodesign Precision Medicine Obtains Deep Tech Development Funding for Its ANIMUS Program

Oncodesign Precision Medicine annonce le résultat de son augmentation de capital d’un montant d’environ 2 M€

Oncodesign Precision Medicine obtient des subventions FEDER d’un montant total de 2,1 M€ pour son programme COMETE

Oncodesign Precision Medicine : Bilan semestriel du contrat de liquidité confié à la société TP ICAP (Europe)

TP ICAP Midcap Initiates Coverage of Oncodesign Precision Medicine With a “Buy” Recommendation

Oncodesign Precision Medicine Announces a 6 Million Euros Bank Financing from Caisse d’Épargne Bourgogne Franche Comté, Crédit Agricole de Champagne Bourgogne and Société Générale

OPM Announces Positive Interim Results of Its Phase 1 Study Evaluating OPM-101 in Healthy Volunteers

OPM met à disposition son rapport financier du 1er semestre 2023

OPM annonce ses résultats du 1er semestre 2023

ALOPM Discussion

Your Recent History